skip to main content

S. 1309 (99th): Health Research Extension Act of 1985

We don’t have a summary available yet.

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.


7/19/1985--Indefinitely postponed in Senate. (Measure indefinitely postponed in Senate, H.R. 2409 passed in lieu) Health Research Extension Act of 1985 - Amends title IV of the Public Health Service Act (National Research Institutes) to establish as an agency of the Public Health Service the National Institutes of Health (NIH) (abolished as a statutory entity by Reorganization Plan No. 3 of 1966) consisting of the following 12 categorical institutes: (1) the National Cancer Institute; (2) the National Heart, Lung, and Blood Institute; (3) the National Institute of Diabetes and Digestive and Kidney Diseases; (4) the National Institute of Arthritis and Musculoskeletal and Skin Diseases; (5) the National Institute on Aging; (6) the National Institute of Allergy and Infectious Diseases; (7) the National Institute of Child Health and Human Development; (8) the National Institute of Dental Research; (9) the National Eye Institute; (10) the National Institute of Neurological and Communicative Disorders and Stroke; (11) the National Institute of General Medical Sciences; and (12) the National Institute of Environmental Health Sciences. Establishes as agencies within NIH: (1) the National Library of Medicine; (2) the Division of Research Resources; and (3) the John E. Fogarty International Center for Advanced Study in the Health Sciences. Permits the Secretary of Health and Human Services to establish additional research institutes. Permits the Secretary to reorganize the functions of any national research institute and abolish any such institute if it is no longer required. Provides that the NIH shall be headed by a Director, who shall be appointed by the President by and with the advice and consent of the Senate. Requires the Secretary to transmit a biennial report, prepared by the Director, to the President and the Congress. Provides that the Director of the National Cancer Institute shall be appointed by the President, and the Directors of the other national research institutes shall be appointed by the Secretary. Sets forth the general duties of the Secretary (acting through the Director of each national research institute). Authorizes the Secretary to enter into contracts and make grants for research, training, and demonstrations. Directs the Secretary to appoint an advisory council for each institute. Sets forth the duties of such advisory councils. Requires the Director of each institute to prepare a biennial report. Authorizes appropriations through FY 1988. States the general purpose and defines the scope of the National Cancer Institute. Requires the Director to establish an information and education center to collect and disseminate information on cancer. Authorizes the Director to: (1) establish and support the production and distribution of specialized biological materials and therapeutic substances for cancer research, and set safety standards for the use of such materials; (2) support cancer research by foreign nationals outside the United States, encourage collaborative research involving American and foreign participants, and train American scientists abroad and foreign nationals in the United States; (3) support education and training programs; (4) coordinate cancer research by industrial concerns; (5) hire experts and consultants; (6) acquire, repair, and construct facilities; (7) appoint advisory committees; (8) enter into contracts, leases, or other transactions; (9) maintain and operate the International Cancer Research Data Bank; and (10) submit an annual budget estimate to the President. Authorizes the Director to provide for the establishment of cancer research and demonstration centers. Extends the period of support for such centers to five years (with additional extensions of not more than five years). Establishes membership requirements for the President's Cancer Panel. Establishes an Assistant Director for Prevention in the National Cancer Institute. States the general purpose and defines the scope of the National Heart, Lung, and Blood Institute. Lists the goals of the National Heart, Blood Vessel, Lung and Blood Diseases and Blood Resources Program. Allows the Director of the Institute to: (1) hire experts and consultants; (2) acquire, repair, and construct facilities; and (3) make grants to public and nonprofit private entities to assist in meeting the cost of patient care. Provides for the development of centers for research, training, and demonstrations of specified diagnostic, prevention, and treatment methods, including: (1) ten for heart and blood vessel diseases; (2) ten for lung diseases; (3) ten for blood diseases; and (4) ten for sickle cell anemia. Directs the Secretary to establish an Interagency Technical Committee on Heart, Blood Vessel, Lung and Blood Diseases and Blood Resources. Establishes an Assistant Director for Prevention in the National Heart, Lung, and Blood Institute. States the general purpose of the National Institute of Diabetes and Digestive and Kidney Diseases. Requires the Director to establish: (1) the National Diabetes Data System; (2) the National Diabetes Information Clearinghouse; (3) the National Digestive Diseases Data System; (4) the National Digestive Diseases Information Clearinghouse; (5) the National Kidney and Urologic Data System; (6) the National Kidney and Urologic Diseases Information Clearinghouse. Establishes positions of Division Director for: (1) Diabetes, Endocrinology, and Metabolic Diseases; (2) Digestive Diseases and Nutrition; and (3) Kidney, Urologic, and Hematologic Diseases. Requires the Secretary to establish: (1) a Diabetes Mellitus Interagency Coordinating Committee; (2) a Digestive Diseases Interagency Coordinating Committee; and (3) a Kidney, Urologic, and Hematologic Diseases Coordinating Committee. Requires such committees to prepare annual reports for the Director of NIH, the Secretary, and the Advisory Board established under this Act for the related disease. Directs the Secretary to establish: (1) the National Diabetes Advisory Board; (2) the National Digestive Diseases Advisory Board; and (3) the National Kidney and Urologic Diseases Advisory Board. Provides for the composition, purposes, and duties of such Advisory Boards. Requires each Advisory Board to prepare an annual report for the Secretary. Provides for the expiration of each Advisory Board on September 30, 1988. Terminates the now existing National Diabetes Advisory Board and National Digestive Diseases Advisory Board upon the appointment of a successor Board. Provides for the development or substantial expansion of centers for research and training in: (1) diabetes mellitus and related endocrine and metabolic diseases; (2) digestive diseases and related functional, congenital, metabolic disorders, and normal development of the digestive tract; and (3) kidney and urologic diseases. States that support for such centers shall be for a period of up to five years (with additional extensions of up to five years). States the general purpose of the National Institute of Arthritis and Musculoskeletal and Skin Diseases. Requires the Director of the Institute to prepare a plan for a national arthritis and musculoskeletal diseases program. Establishes the National Arthritis and Musculoskeletal and Skin Diseases Data System, and the National Arthritis and Musculoskeletal and Skin Diseases Information Clearinghouse. Establishes the Arthritis and Musculoskeletal Diseases Interagency Coordinating Committee, and the Skin Diseases Interagency Coordinating Committee. Requires each such committee to prepare annual reports. Authorizes the Director to make grants to public and private nonprofit entities to establish arthritis and musculoskeletal demonstration projects. Provides for the development, modernization, and operation of new and existing centers for arthritis and musculoskeletal diseases. States that support for such centers shall be for a period of up to five years (with additional extensions of up to five years). Establishes the National Arthritis Advisory Board. Provides for the composition, purposes and duties of such Board. Requires such Board to prepare an annual report for the Secretary. Terminates the now existing National Arthritis Advisory Board upon the appointment of the successor Board. Sets forth the general purpose of the National Institute on Aging. Requires the Director of the Institute to make grants to public and nonprofit private institutions to conduct research relating to Alzheimer's Disease. Sets forth the general purposes of the National Institute of Allergy and Infectious Diseases. States the general purpose of the National Institute of Child Health and Human Development. Requires the Director to conduct and support research relating to sudden infant death syndrome. Requires the Director to make grants for research into the causes, prevention, and treatment of mental retardation. Establishes the position of Assistant Director for Prevention in the National Institute of Child Health and Human Development. States the general purpose of the National Institute of Dental Research and the National Eye Institute. Sets forth the general purpose of the National Institute of Neurological and Communicative Disorders and Stroke. Requires the Director to: (1) conduct and support research into spinal cord regeneration; and (2) make grants or enter into contracts for research on the means to overcome paralysis of the extremities through electrical stimulation and the use of computers. States the general purpose of the National Institute of General Medical Sciences, and the National Institute of Environmental Health Sciences. Sets forth the general purpose and functions of the National Library of Medicine. Authorizes appropriations for library facilities. Establishes the National Libraries Assistance Advisory Board. Directs the Secretary to make grants for: (1) training in medical library sciences; (2) special scientific projects and research in medical library sciences; (3) establishing and expanding the resources of medical libraries; (4) the establishment of regional medical libraries; and (5) financial support of biomedical scientific publications. Sets forth the purposes of: (1) the Division of Research Resources; and (2) the John E. Fogarty International Center for Advanced Study in the Health Sciences. Authorizes appropriations for National Research Service Awards through FY 1986. Directs the Secretary to make Visiting Scientist Awards. Directs the Secretary to study the need for and training of biomedical and behavioral research personnel. Directs the Secretary to request the National Academy of Sciences to conduct such study. Requires that a report on the results of such study be transmitted to specified congressional committees biennially. Requires grant or contract recipients to establish a board to review research involving human subjects. Requires the Secretary to establish procedures for periodic, technical, and scientific peer review of NIH research. Requires grant or contract recipients to establish an administrative process to review reports of scientific fraud. Provides for expedited grant procedures in cases of public health emergencies. Requires an annual report to appropriate congressional committees regarding such actions. Directs the Secretary to establish animal research standards, including the formation of animal care committees. Requires grant and contract recipients to meet such standards. Prohibits the conduct or support of research or experimentation on a living human fetus ex utero unless such research or experimentation: (1) may enhance the well-being of the fetus; or (2) will pose no additional risk of suffering, injury, or death and such knowledge cannot be obtained by other means. Requires the Biomedical Ethics Board to report to appropriate congressional committees on the implications of any waiver of the risk standard for protection of human research subjects as applied to fetal research. Requires the Director of NIH to establish a plan for research into methods of biomedical research and experimentation which: (1) does not require the use of animals; (2) reduces the number of animals used; or (3) produces less pain and distress to such animals. Establishes the Lupus Erythematosus Coordinating Committee to plan, develop, coordinate, and implement research on Lupus Erythematosus. Requires the Committee to report to the Congress within 18 months after the effective date of this Act. Provides for the termination of such Committee. Directs the Secretary to conduct a study of the National Research Service Award and report the results of such study to appropriate congressional committees. Establishes the Interagency Committee on Spinal Cord Injury. Requires the Committee to report to the Congress within 18 months after the effective date of this Act. Provides for the termination of such Committee. Directs the Secretary to conduct a study on the adequacy and availability of personnel to meet the needs of the elderly. Requires the Secretary to report the findings of such study to the appropriate congressional committees by March 1, 1986. Establishes the Interagency Committee on Learning Disabilities. Requires the Committee to report to the Congress within 18 months after the effective date of this Act. Provides for the termination of such Committee. Directs the Secretary to review the disease research programs of the National Institute of Diabetes and Digestive and Kidney Diseases to determine whether such research could be more effectively done by other institutes. Establishes the Biomedical Ethics Board to report to the Congress on the ethical issues arising from the delivery of health care and biomedical research. Authorizes appropriations.